Hubei Institute of Biopharmaceutical Industry

Hubei Institute of Biopharmaceutical Industry (HIBI) is a leading research and development organization based in Wuhan, China, primarily serving as the core R&D engine for Humanwell Healthcare. Established in 2011, the institute is dedicated to the discovery and development of innovative drugs, with a strong emphasis on central nervous system (CNS) therapies, including anesthesia and analgesia. HIBI operates as a comprehensive platform that integrates medicinal chemistry, pharmacology, formulation science, and clinical research capabilities. The institute is recognized as a national-level enterprise technology center and provides R&D services to both domestic and international partners. Through its advanced facilities and collaborative approach, HIBI plays a critical role in advancing the biopharmaceutical ecosystem in Hubei province and beyond.